Search for:
  • Sign in
  • Register
  • Reports
  • Interviews
  • Articles
  • Legal & Regulatory
  • Facts & Figures
  • Op-eds
  • Shop
Sunday, April 19, 2026
PharmaBoardroom
Sign In Register
  • Home
  • Country Reports
    • All
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Exclusive interviews
    • All
    • Latest
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Articles
    • All
    • Global
    • Latest
  • Legal & Regulatory
    • All
    • The Pharma Legal Handbook
    • Regulatory, Pricing and Reimbursement
    • Marketing, Manufacturing, Packaging and Labeling
    • Preclinical and Clinical Trials
  • Op-Eds & Contributions
  • InFigures
    • All
    • Rankings
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Library
    • All
    • InFocus
    • InFigures
    • White Papers
  • Media Kit
  • Register
  • About Us
  • Reports
  • Interviews
  • Articles
  • Legal & Regulatory
  • Facts & Figures
  • Op-eds
  • Shop
Luxembourg Pharma Sector Industry Report

Luxembourg

January 2017

This report offers companies, investors, policymakers, and stakeholders crucial insight into Luxembourg; a country that is rapidly breaking away from its reputation as simply a tiny European tax haven and establishing itself as a serious regional and global healthcare and life sciences player. Luxembourg has prioritized personalized healthcare; e-health and data security; and pharma logistics and air freight as the three pillars of its healthcare strategy and is reaping the rewards.

The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Luxembourgish healthcare and pharma sectors.

This report offers companies, investors, policymakers, and stakeholders crucial insight into Luxembourg; a country that is rapidly breaking away from its reputation as simply a tiny European tax haven and establishing itself as a serious regional and global healthcare and life sciences player. Luxembourg has prioritized personalized healthcare; e-health and data security; and pharma logistics and air freight as the three pillars of its healthcare strategy and is reaping the rewards.

The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Luxembourgish healthcare and pharma sectors.

See more

Legal & Regulatory

report
Buy
Tags: Luxembourg, Pharma, Healthcare, Logistics, R&D, Investment
Share on Linkedin Share

Sharing Link

or sharing via

WhatsApp Email
Back
PharmaBoardroom

PharmaBoardroom Limited
Evolution House
Iceni Court, Delft Way,
Norwich, NR6 6BB UK

Latest

  • Articles
  • In Conversation
  • Facts & Figures
  • Country Reports
  • Legal & Regulatory
  • InFocus

More

  • About Us
  • Media Kit

Join Us

  • Email Newsletters
  • LinkedIn

Contact

+44 0 207 870 3438

info@alpha.pharma.kalyna.dev

Legal & Privacy

  • Terms and Conditions
  • Privacy and Cookies policy
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here

logo

Sign in

Forgot password? Register now